These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 34237335)

  • 1. Mucormycosis: An opportunistic pathogen during COVID-19.
    Mahalaxmi I; Jayaramayya K; Venkatesan D; Subramaniam MD; Renu K; Vijayakumar P; Narayanasamy A; Gopalakrishnan AV; Kumar NS; Sivaprakash P; Sambasiva Rao KRS; Vellingiri B
    Environ Res; 2021 Oct; 201():111643. PubMed ID: 34237335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post COVID-19 rhinocerebral mucormycosis: a case report and literature review.
    El Korbi A; Bhar S; Bergaoui E; Harrathi K; Koubaa J
    Pan Afr Med J; 2022; 42():202. PubMed ID: 36284570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
    Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
    J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications.
    Gurunathan S; Lee AR; Kim JH
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, Risk Factors, Diagnosis and Treatment of Mucormycosis (Black Fungus): A Review.
    Upadhayay P; Bansal K; Goyal A
    Curr Pharm Biotechnol; 2023; 24(13):1645-1656. PubMed ID: 36941816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucormycosis, past and present: a comprehensive review.
    Gupta I; Baranwal P; Singh G; Gupta V
    Future Microbiol; 2023 Feb; 18():217-234. PubMed ID: 36970978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five probable factors responsible for the COVID-associated mucormycosis outbreak in India.
    Ravindra K; Ahlawat A
    Int J Infect Dis; 2021 Nov; 112():278-280. PubMed ID: 34592439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of COVID with Mycosis in General.
    Kaur G; Kaur R; Sumanpreet ; Kaur M
    Infect Disord Drug Targets; 2024; 24(6):e190124225866. PubMed ID: 38251692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance.
    Islam MR; Rahman MM; Ahasan MT; Sarkar N; Akash S; Islam M; Islam F; Aktar MN; Saeed M; Harun-Or-Rashid M; Hosain MK; Rahaman MS; Afroz S; Bibi S; Rahman MH; Sweilam SH
    Environ Sci Pollut Res Int; 2022 Oct; 29(46):69341-69366. PubMed ID: 35986111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mucormycosis in the time of COVID-19: risks and challenges].
    Seidel D; Sal E; Nacov JA; Cornely OA; Kurzai O
    Dtsch Med Wochenschr; 2024 May; 149(10):569-578. PubMed ID: 38657596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucormycosis, The Deadly New Worry to COVID-19 Pandemic.
    Kamrul-Hasan AB; Selim S
    Mymensingh Med J; 2021 Jul; 30(3):874-880. PubMed ID: 34226483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
    Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
    Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and mucormycosis superinfection: the perfect storm.
    Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
    Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): a clinical and diagnostic perspective from India.
    Singh K; Kumar S; Shastri S; Sudershan A; Mansotra V
    Immunogenetics; 2022 Apr; 74(2):197-206. PubMed ID: 34596728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging cases of mucormycosis under COVID-19 pandemic in India: Misuse of antibiotics.
    Gupta G; S R; Singh Y; Thangavelu L; Singh SK; Dureja H; Chellappan DK; Dua K
    Drug Dev Res; 2021 Nov; 82(7):880-882. PubMed ID: 34323298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucormycosis in COVID-19 pandemic: Risk factors and linkages.
    Kumar M; Sarma DK; Shubham S; Kumawat M; Verma V; Singh B; Nagpal R; Tiwari RR
    Curr Res Microb Sci; 2021 Dec; 2():100057. PubMed ID: 34396355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak of Mucormycosis in Coronavirus Disease Patients, Pune, India.
    Joshi S; Telang R; Tambe M; Havaldar R; Sane M; Shaikh A; Roy C; Yathati K; Sonawale S; Borkar R; Magar R; Bhitkar H; Shitole S; Nakate L; Kudrimoti J; Mave V
    Emerg Infect Dis; 2022 Jan; 28(1):1-8. PubMed ID: 34586055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucormycosis and Its Upsurge During COVID-19 Epidemic: An Updated Review.
    Sharma B; Nonzom S
    Curr Microbiol; 2023 Aug; 80(10):322. PubMed ID: 37592083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 associated mucormycosis (CAM) in India: a formidable challenge.
    Rao VUS; Arakeri G; Madikeri G; Shah A; Oeppen RS; Brennan PA
    Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1095-1098. PubMed ID: 34507870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic.
    Gambhir RS; Aggarwal A; Bhardwaj A; Kaur A; Sohi RK; Mehta S
    Rocz Panstw Zakl Hig; 2021; 72(3):239-244. PubMed ID: 34553877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.